Published in Int J Dermatol on May 01, 1989
A clinical and histopathological profile of patients with cutaneous tuberculosis. Indian J Dermatol (2011) 1.39
Autoinoculation lupus vulgaris of the perineum. Genitourin Med (1991) 1.39
Tuberculosis verrucosa cutis presenting as diffuse plantar keratoderma: an unusual sight. Indian J Dermatol (2014) 1.18
Incidence of various clinico-morphological variants of cutaneous tuberculosis and HIV concurrence: a study from the Indian subcontinent. Ann Saudi Med (2011) 1.08
Lymphoedema of the genitalia secondary to skin tuberculosis: report of three cases. Genitourin Med (1997) 1.07
Tuberculosis verrucosa cutis developing over a keloid: a rare presentation. J Surg Tech Case Rep (2010) 0.92
Update on cutaneous tuberculosis. An Bras Dermatol (2014) 0.77
Tuberculosis verrucosa cutis in a patient with keloid over ear lobule. BMJ Case Rep (2013) 0.75
Cutaneous tuberculosis of gluteal region presenting as a sinus and large cyst: an unusual entity. J Cutan Aesthet Surg (2011) 0.75
Infectious Granulomatous Dermatitis at a Tertiary Care Centre in North Maharashtra: A Histopathological Study. J Clin Diagn Res (2016) 0.75
A wireless, remote query ammonia sensor. Sens Actuators B Chem (2001) 9.00
Environmental and physiological factors affecting the succinate product ratio during carbohydrate fermentation by Actinobacillus sp. 130Z. Arch Microbiol (1997) 2.25
Human EZF, a Krüppel-like zinc finger protein, is expressed in vascular endothelial cells and contains transcriptional activation and repression domains. J Biol Chem (1998) 2.15
1-Cys peroxiredoxin, a bifunctional enzyme with glutathione peroxidase and phospholipase A2 activities. J Biol Chem (2000) 2.00
Functional epigenetics identifies a protocadherin PCDH10 as a candidate tumor suppressor for nasopharyngeal, esophageal and multiple other carcinomas with frequent methylation. Oncogene (2006) 1.82
Thy-1, a novel marker for angiogenesis upregulated by inflammatory cytokines. Circ Res (1998) 1.81
Interfacial enzymology: the secreted phospholipase A(2)-paradigm. Chem Rev (2001) 1.71
Trichotillomania +/- trichobezoar: revisited. J Eur Acad Dermatol Venereol (2006) 1.62
Identification of differentially expressed genes in esophageal squamous cell carcinoma (ESCC) by cDNA expression array: overexpression of Fra-1, Neogenin, Id-1, and CDC25B genes in ESCC. Clin Cancer Res (2001) 1.60
Histoid leprosy. Int J Dermatol (1985) 1.55
Actinobacillus succinogenes sp. nov., a novel succinic-acid-producing strain from the bovine rumen. Int J Syst Bacteriol (1999) 1.53
Cardiovascular basic helix loop helix factor 1, a novel transcriptional repressor expressed preferentially in the developing and adult cardiovascular system. J Biol Chem (2000) 1.49
TCR-CD56+CD2+ nasal lymphomas with membrane-localized CD3 positivity: are the CD3+ cells neoplastic or reactive? Blood (1995) 1.47
Transforming growth factor-beta 1 inhibits cytokine-mediated induction of human metalloelastase in macrophages. J Biol Chem (2000) 1.46
Biology, ecology, and biotechnological applications of anaerobic bacteria adapted to environmental stresses in temperature, pH, salinity, or substrates. Microbiol Rev (1993) 1.44
The pili of Pseudomonas aeruginosa strains PAK and PAO bind specifically to the carbohydrate sequence beta GalNAc(1-4)beta Gal found in glycosphingolipids asialo-GM1 and asialo-GM2. Mol Microbiol (1994) 1.43
Successful treatment of antimony-resistant visceral leishmaniasis with liposomal amphotericin B (L-AmpB-LRC) in a child. Trop Doct (1995) 1.43
Role of phospholipids in transport and enzymic reactions. Adv Lipid Res (1974) 1.42
Effects of garlic extract and of three pure components isolated from it on human platelet aggregation, arachidonate metabolism, release reaction and platelet ultrastructure. Thromb Res (1983) 1.40
Clinicohistological disparity in leprosy. Indian J Dermatol Venereol Leprol (2007) 1.39
Transforming growth factor-beta 1 inhibition of macrophage activation is mediated via Smad3. J Biol Chem (2000) 1.38
Reconstitution of an ATP-mediated active transport system across black lipid membranes. Nature (1969) 1.37
Genomic analyses reveal global functional alterations that promote tumor growth and novel tumor suppressor genes in natural killer-cell malignancies. Leukemia (2009) 1.35
Nasal NK- and T-cell lymphomas share the same type of Epstein-Barr virus latency as nasopharyngeal carcinoma and Hodgkin's disease. Int J Cancer (1996) 1.32
Intrinsic perturbing ability of alkanols in lipid bilayers. Biochim Biophys Acta (1978) 1.32
Microbial utilization of electrically reduced neutral red as the sole electron donor for growth and metabolite production. Appl Environ Microbiol (1999) 1.31
Methylation status of the Epstein-Barr virus major latent promoter C in iatrogenic B cell lymphoproliferative disease. Application of PCR-based analysis. Am J Pathol (1999) 1.31
Complete nucleotide sequence of hepatic 5-aminolaevulinate synthase precursor. Eur J Biochem (1985) 1.31
Role of vitamin D in pulmonary tuberculosis. J Assoc Physicians India (1984) 1.31
Tight binding inhibitors of 85-kDa phospholipase A2 but not 14-kDa phospholipase A2 inhibit release of free arachidonate in thrombin-stimulated human platelets. J Biol Chem (1994) 1.29
An appraisal of epidemiologic, clinical, bacteriologic, histopathologic, and immunologic parameters in cutaneous tuberculosis. Int J Dermatol (1987) 1.29
Follicular dendritic cell tumor of the liver. Evidence for an Epstein-Barr virus-related clonal proliferation of follicular dendritic cells. Am J Surg Pathol (1996) 1.28
Interfacial enzymology of glycerolipid hydrolases: lessons from secreted phospholipases A2. Annu Rev Biochem (1995) 1.26
Long-range order in biomembranes. Adv Lipid Res (1977) 1.25
Evidence for lytic infection by Epstein-Barr virus in mucosal lymphocytes instead of nasopharyngeal epithelial cells in normal individuals. J Med Virol (1995) 1.25
Nucleotide sequence of the chicken 5-aminolevulinate synthase gene. Nucleic Acids Res (1986) 1.23
Epigenetic identification of ADAMTS18 as a novel 16q23.1 tumor suppressor frequently silenced in esophageal, nasopharyngeal and multiple other carcinomas. Oncogene (2007) 1.21
Generation of a dominant-negative mutant of endothelial PAS domain protein 1 by deletion of a potent C-terminal transactivation domain. J Biol Chem (1999) 1.20
Presence of Epstein-Barr virus DNA in nasal lymphomas of B and 'T' cell type. Hematol Oncol (1991) 1.19
Vascular endothelium and atherosclerosis. Handb Exp Pharmacol (2006) 1.19
Regulation of myogenic terminal differentiation by the hairy-related transcription factor CHF2. J Biol Chem (2001) 1.19
Profiling of differentially expressed cancer-related genes in esophageal squamous cell carcinoma (ESCC) using human cancer cDNA arrays: overexpression of oncogene MET correlates with tumor differentiation in ESCC. Clin Cancer Res (2001) 1.18
Assessment of arterial elasticity among HIV-positive participants with high CD4 cell counts: a substudy of the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial. HIV Med (2015) 1.17
Interfacial catalysis by phospholipase A2: determination of the interfacial kinetic rate constants. Biochemistry (1991) 1.16
Epigenetic disruption of interferon-gamma response through silencing the tumor suppressor interferon regulatory factor 8 in nasopharyngeal, esophageal and multiple other carcinomas. Oncogene (2008) 1.16
A case of scrub typhus probably acquired in Africa. Clin Infect Dis (1997) 1.11
Reductive dechlorination of DDE to DDMU in marine sediment microcosms. Science (1998) 1.11
Formation of Fatty Acid-degrading, anaerobic granules by defined species. Appl Environ Microbiol (1996) 1.10
Phospholipase A2 at the bilayer interface. Proteins (1991) 1.09
Enhancement of serum-response factor-dependent transcription and DNA binding by the architectural transcription factor HMG-I(Y). J Biol Chem (1998) 1.09
Id-1 and Id-2 are markers for metastasis and prognosis in oesophageal squamous cell carcinoma. Br J Cancer (2007) 1.09
Human papillomavirus 6, 11, and 16 in laryngeal papillomas. J Pathol (1991) 1.09
Comparison of assimilatory organic nitrogen, sulfur, and carbon sources for growth of methanobacterium species. Appl Environ Microbiol (1984) 1.08
Identification of a human cDNA clone for lysosomal type Ca2+-independent phospholipase A2 and properties of the expressed protein. J Biol Chem (1997) 1.08
Histoid leprosy: a prospective diagnostic study in 38 patients. Dermatologica (1988) 1.06
Cationic peptide antimicrobials induce selective transcription of micF and osmY in Escherichia coli. Biochim Biophys Acta (2000) 1.05
Ajoene, the antiplatelet principle of garlic, synergistically potentiates the antiaggregatory action of prostacyclin, forskolin, indomethacin and dypiridamole on human platelets. Thromb Res (1986) 1.05
Activation of the beta-galactoside transport system in Escherichia coli ML-308 by n-alkanols. Modification of lipid-protein interaction by a change in bilayer fluidity. Biochim Biophys Acta (1974) 1.05
Identification of a tumor suppressive critical region mapping to 3p14.2 in esophageal squamous cell carcinoma and studies of a candidate tumor suppressor gene, ADAMTS9. Oncogene (2006) 1.05
Drug-induced phase change in bilayer as possible mode of action of membrane expanding drugs. Nature (1975) 1.04
Fimbria-mediated adherence of Candida albicans to glycosphingolipid receptors on human buccal epithelial cells. Infect Immun (1994) 1.03
Epstein-Barr virus DNA in nasopharyngeal carcinomas from Chinese patients in Hong Kong. J Clin Pathol (1992) 1.02
Phosphatidylinositol-specific phospholipase C from Bacillus cereus at the lipid-water interface: interfacial binding, catalysis, and activation. Biochemistry (1994) 1.02
Osmotic stress in viable Escherichia coli as the basis for the antibiotic response by polymyxin B. Biochem Biophys Res Commun (1998) 1.01
Interaction of phospholipase A2 and phospholipid bilayers. Biochim Biophys Acta (1982) 1.01
The human cadherin 11 is a pro-apoptotic tumor suppressor modulating cell stemness through Wnt/β-catenin signaling and silenced in common carcinomas. Oncogene (2011) 1.00
Effect of surgical experience on results of esophagectomy for esophageal carcinoma. J Surg Oncol (1997) 1.00
A novel isoform of the 8p22 tumor suppressor gene DLC1 suppresses tumor growth and is frequently silenced in multiple common tumors. Oncogene (2011) 1.00
Epstein-Barr-virus-infected nasopharyngeal intraepithelial lymphocytes. Lancet (1995) 0.99
Fatty acid biosynthesis in yeast. Mol Cell Biochem (1978) 0.99
Evidence that in chick embryos destruction of hepatic microsomal cytochrome P-450 haem is a general mechanism of induction of delta-aminolaevulinate synthase by porphyria-causing drugs. Biochem J (1980) 0.99
Malignant lymphoma of the thyroid. A 30-year clinicopathologic experience and an evaluation of the presence of Epstein-Barr virus. Am J Clin Pathol (1999) 0.99
SOCS1 and SHP1 hypermethylation in mantle cell lymphoma and follicular lymphoma: implications for epigenetic activation of the Jak/STAT pathway. Leukemia (2004) 0.99
Establishment and characterization of HKESC-1, a new cancer cell line from human esophageal squamous cell carcinoma. Cancer Genet Cytogenet (2000) 0.99
Re-infection (secondary) inoculation cutaneous tuberculosis. Int J Dermatol (2001) 0.98
Status of histoid leprosy--a clinical, bacteriological, histopathological and immunological appraisal. J Dermatol (1987) 0.98
Do membrane-bound enzymes access their substrates from the membrane or aqueous phase: interfacial versus non-interfacial enzymes. Biochim Biophys Acta (2000) 0.98
Origin of the latency phase during the action of phospholipase A2 on unmodified phosphatidylcholine vesicles. Biochim Biophys Acta (1982) 0.98
Overexpression and point mutations of p53 tumor suppressor gene in hepatocellular carcinomas in Hong Kong Chinese people. Cancer (1994) 0.97
Detection of clonal Epstein-Barr virus in malignant proliferation of peripheral blood CD3+ CD8+ T cells. Leukemia (1992) 0.97
The spontaneous incorporation of proteins into preformed bilayers. Biochim Biophys Acta (1987) 0.97
Epstein-Barr virus is localized in the tumour cells of nasal lymphomas of NK, T or B cell type. Int J Cancer (1995) 0.97
Mitogen-activated protein kinase phosphatase-1 in rat arterial smooth muscle cell proliferation. J Clin Invest (1996) 0.96
Prevalence of six types of human papillomavirus in inverted papilloma and papillary transitional cell carcinoma of the bladder: an evaluation by polymerase chain reaction. J Clin Pathol (1997) 0.95
Control of 5-aminolevulinate synthase in animals. Curr Top Cell Regul (1986) 0.95
Aortic carboxypeptidase-like protein, a novel protein with discoidin and carboxypeptidase-like domains, is up-regulated during vascular smooth muscle cell differentiation. J Biol Chem (1998) 0.95
E-cadherin expression is commonly downregulated by CpG island hypermethylation in esophageal carcinoma cells. Cancer Lett (2001) 0.95
Tissue section Donovan bodies--identification through slow-Giemsa (overnight) technique. Dermatologica (1987) 0.95
Latent sites of Epstein-Barr virus infection. Am J Clin Pathol (1993) 0.94
Evidence for direct coupling of primary agonist-receptor interaction to the exposure of functional IIb-IIIa complexes in human blood platelets. Results from studies with the antiplatelet compound ajoene. Biochim Biophys Acta (1991) 0.94
Ajoene, the antiplatelet compound derived from garlic, specifically inhibits platelet release reaction by affecting the plasma membrane internal microviscosity. Biochem Pharmacol (1989) 0.94
Evaluation of deoxygenated oligosaccharide acceptor analogs as specific inhibitors of glycosyltransferases. J Biol Chem (1991) 0.94
Purification of 5-aminolaevulinate synthase from liver mitochondria of chick embryo. Eur J Biochem (1983) 0.94
Phospholipase A2-catalyzed hydrolysis of vesicles: uses of interfacial catalysis in the scooting mode. Methods Enzymol (1991) 0.94
Isolation of homogeneous phospholipase A2 from human platelets. Biochem Biophys Res Commun (1979) 0.94
Human papillomavirus in oesophageal squamous cell carcinoma. J Clin Pathol (1990) 0.94
Comparative analysis of Epstein-Barr virus gene polymorphisms in nasal T/NK-cell lymphomas and normal nasal tissues: implications on virus strain selection in malignancy. Int J Cancer (1999) 0.93